|
|
|
|
| LEADER |
02975nam a22003615i 4500 |
| 001 |
978-0-387-68969-2 |
| 005 |
20191021223345.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2008 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9780387689692
|
| 024 |
7 |
|
|a 10.1007/978-0-387-68969-2
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Ovarian Cancer
|b State of the Art and Future Directions in Translational Research /
|c edited by George Coukos, Andrew Berchuck, Robert Ozols.
|
| 250 |
|
|
|a 1st ed. 2008.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2008.
|
| 300 |
|
|
|a XII, 308 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|v 622
|
| 505 |
0 |
|
|a Ovarian Cancer Detection and Pathogenesis -- Potential and Limitations in Early Diagnosis of Ovarian Cancer -- SMRP and HE4 as Biomarkers for Ovarian Carcinoma When Used Alone and in Combination with CA125 and/or Each Other -- Classification of Ovarian Cancer: A Genomic Analysis -- Epigenetic Markers of Ovarian Cancer -- Role of Genetic Polymorphisms in Ovarian Cancer Susceptibility: Development of an International Ovarian Cancer Association Consortium -- MicroRNA in Human Cancer: One Step Forward in Diagnosis and Treatment -- Ovarian Carcinogenesis: An Alternative Hypothesis -- BRCA1-Induced Ovarian Oncogenesis -- Role of p53 and Rb in Ovarian Cancer -- Ovulatory Factor in Ovarian Carcinogenesis -- Ovarian Cancer Therapeutics -- Gynecologic Oncology Group (GOG-USA) Trials in Ovarian Cancer -- Intraperitoneal Chemotherapy for Ovarian Cancer -- Ovarian Cancer: Can We Reverse Drug Resistance? -- Syngeneic Mouse Model of Epithelial Ovarian Cancer: Effects of Nanoparticulate Paclitaxel, Nanotax® -- Individualized Molecular Medicine: Linking Functional Proteomics to Select Therapeutics Targeting the PI3K Pathway for Specific Patients -- Defective Apoptosis Underlies Chemoresistance in Ovarian Cancer -- Nanoparticle Delivery of Suicide DNA for Epithelial Ovarian Cancer Therapy -- Biological Therapy with Oncolytic Herpesvirus -- Cancer Immunotherapy: Perspectives and Prospects -- Regulatory T Cells: A New Frontier in Cancer Immunotherapy -- Inhibitory B7 Family Members in Human Ovarian Carcinoma -- Role of Vascular Leukocytes in Ovarian Cancer Neovascularization -- Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a New Target Molecule for Cancer Therapy.
|
| 650 |
|
0 |
|a Oncology .
|
| 650 |
|
0 |
|a Cancer research.
|
| 650 |
|
0 |
|a Life sciences.
|
| 650 |
1 |
4 |
|a Oncology.
|
| 650 |
2 |
4 |
|a Cancer Research.
|
| 650 |
2 |
4 |
|a Life Sciences, general.
|
| 700 |
1 |
|
|a Coukos, George.
|e editor.
|
| 700 |
1 |
|
|a Berchuck, Andrew.
|e editor.
|
| 700 |
1 |
|
|a Ozols, Robert.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-0-387-68969-2
|